118 related articles for article (PubMed ID: 35349366)
1. A Novel External Auditory Canal Squamous Cell Carcinoma Cell Line Sensitive to CDK4/6 Inhibition.
García-Marín R; Cabal VN; Fernández-Cedrón Bermejo C; Riobello C; Suárez-Fernández L; Codina-Martínez H; Navarro-García A; Lorenzo-Guerra SL; García-Martínez J; Vivanco B; López F; Llorente JL; Hermsen MA
Otolaryngol Head Neck Surg; 2023 Apr; 168(4):729-737. PubMed ID: 35349366
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics and Management of External Auditory Canal Squamous Cell Carcinoma in Post-Irradiated Nasopharyngeal Carcinoma Patients.
Wang J; Xie B; Dai C
Otol Neurotol; 2015 Jul; 36(6):1081-8. PubMed ID: 25839976
[TBL] [Abstract][Full Text] [Related]
3. Biological and genetic characterization of a newly established human external auditory canal carcinoma cell line, SCEACono2.
Komune N; Sato K; Ono M; Imaizumi A; Masuda S; Itoyama S; Manako T; Kuga R; Hongo T; Kogo R; Onishi H; Nakagawa T
Sci Rep; 2023 Nov; 13(1):19636. PubMed ID: 37949965
[TBL] [Abstract][Full Text] [Related]
4. Genetic landscape of external auditory canal squamous cell carcinoma.
Sato K; Komune N; Hongo T; Koike K; Niida A; Uchi R; Noda T; Kogo R; Matsumoto N; Yamamoto H; Masuda M; Oda Y; Mimori K; Nakagawa T
Cancer Sci; 2020 Aug; 111(8):3010-3019. PubMed ID: 32500594
[TBL] [Abstract][Full Text] [Related]
5. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
[TBL] [Abstract][Full Text] [Related]
6. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
[TBL] [Abstract][Full Text] [Related]
7. CDK4/6 inhibitors in P16/HPV16-negative squamous cell carcinoma of the head and neck.
Billard-Sandu C; Tao YG; Sablin MP; Dumitrescu G; Billard D; Deutsch E
Eur Arch Otorhinolaryngol; 2020 May; 277(5):1273-1280. PubMed ID: 32162057
[TBL] [Abstract][Full Text] [Related]
8. Occult parotid involvement in early-stage squamous cell carcinoma of the external auditory canal.
Chang JW; Lee S; Lee JM; Moon IS; Cho YS; Cho YS; Choi JW
Head Neck; 2021 Sep; 43(9):2655-2662. PubMed ID: 33938083
[TBL] [Abstract][Full Text] [Related]
9. Poorly Differentiated Clusters Predict a Poor Prognosis for External Auditory Canal Carcinoma.
Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Kiyomi F; Sakata T; Nakagawa T; Nabeshima K
Head Neck Pathol; 2019 Jun; 13(2):198-207. PubMed ID: 29846906
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target.
Ouyang Z; Wang S; Zeng M; Li Z; Zhang Q; Wang W; Liu T
Cell Commun Signal; 2019 Feb; 17(1):17. PubMed ID: 30808351
[TBL] [Abstract][Full Text] [Related]
11. SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy).
Edelman MJ; Redman MW; Albain KS; McGary EC; Rafique NM; Petro D; Waqar SN; Minichiello K; Miao J; Papadimitrakopoulou VA; Kelly K; Gandara DR; Herbst RS
J Thorac Oncol; 2019 Oct; 14(10):1853-1859. PubMed ID: 31302234
[TBL] [Abstract][Full Text] [Related]
12. Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancer.
Cao J; Zhu Z; Wang H; Nichols TC; Lui GYL; Deng S; Rejto PA; VanArsdale T; Hardwick JS; Weinrich SL; Wei P
Oncogene; 2019 May; 38(21):4125-4141. PubMed ID: 30700828
[TBL] [Abstract][Full Text] [Related]
13. Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?
Kalu NN; Johnson FM
Expert Opin Investig Drugs; 2017 Feb; 26(2):207-217. PubMed ID: 28042706
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of inflammatory response markers for locally advanced squamous cell carcinoma of the external auditory canal and middle ear.
Makita K; Hamamoto Y; Takata N; Ishikawa H; Tsuruoka S; Uwatsu K; Hato N; Kido T
J Radiat Res; 2021 Jul; 62(4):662-668. PubMed ID: 34115873
[TBL] [Abstract][Full Text] [Related]
15. Association of gene mutations with clinicopathologic features in patients with external auditory canal squamous cell carcinoma.
Morita S; Kano S; Hatanaka KC; Hatanaka Y; Suzuki T; Fukuda A; Hoshino K; Fujiwara K; Nakamaru Y; Homma A
Int J Clin Oncol; 2022 Sep; 27(9):1394-1403. PubMed ID: 35698008
[TBL] [Abstract][Full Text] [Related]
16. Radiological Findings of Malignant Tumors of External Auditory Canal: A Cross-Sectional Study Between Squamous Cell Carcinoma and Adenocarcinoma.
Xia S; Yan S; Zhang M; Cheng Y; Noel J; Chong V; Shen W
Medicine (Baltimore); 2015 Sep; 94(35):e1452. PubMed ID: 26334907
[TBL] [Abstract][Full Text] [Related]
17. CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma.
Zhou J; Wu Z; Wong G; Pectasides E; Nagaraja A; Stachler M; Zhang H; Chen T; Zhang H; Liu JB; Xu X; Sicinska E; Sanchez-Vega F; Rustgi AK; Diehl JA; Wong KK; Bass AJ
Nat Commun; 2017 Jan; 8():13897. PubMed ID: 28059068
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of subclasses for T4-classified squamous cell carcinoma of the external auditory canal.
Nabuurs CH; Kievit W; Leemans CR; Smit CFGM; van den Brekel MWM; Pauw RJ; van der Laan BFAM; Jansen JC; Lacko M; Braunius WW; Dai C; Shi X; Danesi G; Bouček J; Takes RP; Kunst HPM
Head Neck; 2022 Aug; 44(8):1787-1798. PubMed ID: 35560966
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
20. Pseudoepitheliomatous hyperplasia versus squamous cell carcinoma of the external auditory canal.
Gacek MR; Gacek RR; Gantz B; McKenna M; Goodman M
Laryngoscope; 1998 Apr; 108(4 Pt 1):620-3. PubMed ID: 9546281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
